-
2
-
-
0037050352
-
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
-
Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 2002;346:92-98.
-
(2002)
N Engl J Med
, vol.346
, pp. 92-98
-
-
Schiller, J.H.1
Harrington, D.2
Belani, C.P.3
-
3
-
-
0037214171
-
A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer
-
Massarelli E, Andre F, Liu DD, et al. A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer. Lung Cancer. 2003;39:55-61.
-
(2003)
Lung Cancer
, vol.39
, pp. 55-61
-
-
Massarelli, E.1
Andre, F.2
Liu, D.D.3
-
5
-
-
0347364778
-
Targeting the epidermal growth factor receptor in non-small cell lung cancer
-
Herbst R, Bunn PA Jr. Targeting the epidermal growth factor receptor in non-small cell lung cancer. Clin Cancer Res. 2003;9:5813-5824.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 5813-5824
-
-
Herbst, R.1
Bunn Jr., P.A.2
-
6
-
-
0034644539
-
Cell signaling by receptor tyrosine kinases
-
Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2000;103:211-225.
-
(2000)
Cell
, vol.103
, pp. 211-225
-
-
Schlessinger, J.1
-
7
-
-
40849147041
-
EGFR antagonists in cancer treatment
-
Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med. 2008;358:1160-1174.
-
(2008)
N Engl J Med
, vol.358
, pp. 1160-1174
-
-
Ciardiello, F.1
Tortora, G.2
-
8
-
-
56249109644
-
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): A randomised phase III trial
-
Kim ES, Hirsh V, Mok T, et al. Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial. Lancet. 2008;372:1809-1818.
-
(2008)
Lancet
, vol.372
, pp. 1809-1818
-
-
Kim, E.S.1
Hirsh, V.2
Mok, T.3
-
9
-
-
27544503230
-
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: Results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
-
Thatcher N, Chang A, Parikh P, et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer). Lancet. 2005;366:1527-1537.
-
(2005)
Lancet
, vol.366
, pp. 1527-1537
-
-
Thatcher, N.1
Chang, A.2
Parikh, P.3
-
10
-
-
33646867322
-
Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer
-
Cufer T, Vrdoljak E, Gaafar R, et al. Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer. Anticancer Drugs. 2006;17:401-409.
-
(2006)
Anticancer Drugs
, vol.17
, pp. 401-409
-
-
Cufer, T.1
Vrdoljak, E.2
Gaafar, R.3
-
11
-
-
74949133978
-
American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer
-
Azzoli CG, Baker S Jr, Temin S, et al. American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol. 2009;27:6251-6266.
-
(2009)
J Clin Oncol
, vol.27
, pp. 6251-6266
-
-
Azzoli, C.G.1
Baker Jr., S.2
Temin, S.3
-
12
-
-
63749100778
-
Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases
-
Rusthoven KE, Kavanagh BD, Burri SH, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol. 2009;27:1579-1584.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1579-1584
-
-
Rusthoven, K.E.1
Kavanagh, B.D.2
Burri, S.H.3
-
13
-
-
4844229902
-
Stereotactic hypofractionated high-dose irradiation for stage i non small cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study
-
Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I non small cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer. 2004;101:1623-1631.
-
(2004)
Cancer
, vol.101
, pp. 1623-1631
-
-
Onishi, H.1
Araki, T.2
Shirato, H.3
-
14
-
-
65549125983
-
Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patternsof-failure analysis
-
Rusthoven KE, Hammerman SF, Kavanagh BD, et al. Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patternsof-failure analysis. Acta Oncol. 2009;48:578-583.
-
(2009)
Acta Oncol
, vol.48
, pp. 578-583
-
-
Rusthoven, K.E.1
Hammerman, S.F.2
Kavanagh, B.D.3
-
15
-
-
51449118059
-
Stereotactic body radiotherapy for oligometastatic lung tumors
-
Norihisa Y, Nagata Y, Takayama K, et al. Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys. 2008;72:398-403.
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.72
, pp. 398-403
-
-
Norihisa, Y.1
Nagata, Y.2
Takayama, K.3
-
16
-
-
33748859087
-
Lung tumor tracking during stereotactic radiotherapy treatment with the CyberKnife: Marker placement and early results
-
Nuyttens JJ, Prevost JB, Praag J, et al. Lung tumor tracking during stereotactic radiotherapy treatment with the CyberKnife: marker placement and early results. Acta Oncol. 2006;45:961-965.
-
(2006)
Acta Oncol
, vol.45
, pp. 961-965
-
-
Nuyttens, J.J.1
Prevost, J.B.2
Praag, J.3
-
17
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors
-
Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;92:205-216.
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
-
18
-
-
0036184207
-
What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592
-
Cella D, Eton DT, Fairclough DL, et al. What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592. J Clin Epidemiol. 2002;55:285-295.
-
(2002)
J Clin Epidemiol
, vol.55
, pp. 285-295
-
-
Cella, D.1
Eton, D.T.2
Fairclough, D.L.3
-
19
-
-
1242293093
-
Rationale and clinical basis for combining gefitinib (IRESSA, ZD1839) with radiation therapy for solid tumors
-
Ochs JS. Rationale and clinical basis for combining gefitinib (IRESSA, ZD1839) with radiation therapy for solid tumors. Int J Radiat Oncol Biol Phys. 2004;58:941-949.
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.58
, pp. 941-949
-
-
Ochs, J.S.1
-
20
-
-
69949110700
-
Early CT findings of tomotherapy-induced radiation pneumonitis after treatment of lung malignancy
-
Park HJ, Kim KJ, Park SH, et al. Early CT findings of tomotherapy-induced radiation pneumonitis after treatment of lung malignancy. AJR Am J Roentgenol. 2009;193:209-213.
-
(2009)
AJR Am J Roentgenol
, vol.193
, pp. 209-213
-
-
Park, H.J.1
Kim, K.J.2
Park, S.H.3
-
21
-
-
33646883312
-
Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors
-
Tsuboi M, Le Chevalier T. Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors. Med Oncol. 2006;23:161-170.
-
(2006)
Med Oncol
, vol.23
, pp. 161-170
-
-
Tsuboi, M.1
Le Chevalier, T.2
-
22
-
-
79960055286
-
Upfront gefitinib/erlotinib treatment followed by concomitant radiotherapy for advanced lung cancer: A mono-institutional experience
-
Chang CC, Chi KH, Kao SJ, et al. Upfront gefitinib/erlotinib treatment followed by concomitant radiotherapy for advanced lung cancer: a mono-institutional experience. Lung Cancer. 2011;73: 189-194.
-
(2011)
Lung Cancer
, vol.73
, pp. 189-194
-
-
Chang, C.C.1
Chi, K.H.2
Kao, S.J.3
-
23
-
-
79953777978
-
Single-agent gefitinib with concurrent radiotherapy for locally advanced non-small-cell lung cancer harboring mutations of the epidermal growth factor receptor
-
Okamoto I, Takahashi T, Okamoto H, et al. Single-agent gefitinib with concurrent radiotherapy for locally advanced non-small-cell lung cancer harboring mutations of the epidermal growth factor receptor. Lung Cancer. 2011;72:199-204.
-
(2011)
Lung Cancer
, vol.72
, pp. 199-204
-
-
Okamoto, I.1
Takahashi, T.2
Okamoto, H.3
-
24
-
-
76149123903
-
A phase i study of gefitinib with concurrent dose-escalated weekly docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel and maintenance gefitinib for patients with stage III non-small-cell lung cancer
-
Center B, Petty WJ, Ayala D, et al. A phase I study of gefitinib with concurrent dose-escalated weekly docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel and maintenance gefitinib for patients with stage III non-small-cell lung cancer. J Thorac Oncol. 2010;5:69-74.
-
(2010)
J Thorac Oncol
, vol.5
, pp. 69-74
-
-
Center, B.1
Petty, W.J.2
Ayala, D.3
-
25
-
-
0025009172
-
A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer
-
Dillman RO, Seagren SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med. 1990;323:940-945.
-
(1990)
N Engl J Med
, vol.323
, pp. 940-945
-
-
Dillman, R.O.1
Seagren, S.L.2
Propert, K.J.3
-
26
-
-
0021260822
-
Primary tumor control after radiotherapy for carcinoma of the bronchus
-
Saunders MI, Bennett MH, Dische S, et al. Primary tumor control after radiotherapy for carcinoma of the bronchus. Int J Radiat Oncol Biol Phys. 1984;10:499-501.
-
(1984)
Int J Radiat Oncol Biol Phys
, vol.10
, pp. 499-501
-
-
Saunders, M.I.1
Bennett, M.H.2
Dische, S.3
-
27
-
-
74549188119
-
Systemic review of the patterns of failure following stereotactic body radiation therapy in earlystage non-small-cell lung cancer: Clinical implications
-
Chi A, Liao Z, Nguyen NP, et al. Systemic review of the patterns of failure following stereotactic body radiation therapy in earlystage non-small-cell lung cancer: clinical implications. Radiother Oncol. 2010;94:1-11.
-
(2010)
Radiother Oncol
, vol.94
, pp. 1-11
-
-
Chi, A.1
Liao, Z.2
Nguyen, N.P.3
-
28
-
-
0012381722
-
Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial)
-
Fukuoka M, Yano S, Giaccone G, et al. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial). J Clin Oncol. 2009;27:2237-2246.
-
(2009)
J Clin Oncol
, vol.27
, pp. 2237-2246
-
-
Fukuoka, M.1
Yano, S.2
Giaccone, G.3
-
29
-
-
34248385777
-
Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: Subset analysis from the ISEL study
-
Chang A, Parikh P, Thongprasert S, et al. Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study. J Thorac Oncol. 2006;1:847-855.
-
(2006)
J Thorac Oncol
, vol.1
, pp. 847-855
-
-
Chang, A.1
Parikh, P.2
Thongprasert, S.3
-
30
-
-
52049125250
-
Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer
-
Maruyama R, Nishiwaki Y, Tamura T, et al. Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer. J Clin Oncol. 2008;26: 4244-4252.
-
(2008)
J Clin Oncol
, vol.26
, pp. 4244-4252
-
-
Maruyama, R.1
Nishiwaki, Y.2
Tamura, T.3
-
31
-
-
76749154617
-
Randomized phase III trial of gefitinib versus docetaxel in non-small cell lung cancer patients who have previously received platinum-based chemotherapy
-
Lee DH, Park K, Kim JH, et al. Randomized phase III trial of gefitinib versus docetaxel in non-small cell lung cancer patients who have previously received platinum-based chemotherapy. Clin Cancer Res. 2010;16:1307-1314.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 1307-1314
-
-
Lee, D.H.1
Park, K.2
Kim, J.H.3
-
32
-
-
79958120436
-
A phase II randomized trial of gefitinib alone or with tegafur/uracil treatment in patients with pulmonary adenocarcinoma who had failed previous chemotherapy
-
Chen YM, Fan WC, Tsai CM, et al. A phase II randomized trial of gefitinib alone or with tegafur/uracil treatment in patients with pulmonary adenocarcinoma who had failed previous chemotherapy. J Thorac Oncol. 2011;6:1110-1116.
-
(2011)
J Thorac Oncol
, vol.6
, pp. 1110-1116
-
-
Chen, Y.M.1
Fan, W.C.2
Tsai, C.M.3
-
33
-
-
80255123376
-
Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer
-
Widder J, Postmus D, Ubbels JF, et al. Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer. Int J Radiat Oncol Biol Phys. 2011;81:e291-e297.
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.81
-
-
Widder, J.1
Postmus, D.2
Ubbels, J.F.3
|